Skip to Main Content
Our Commitment to Diversity


Harry Kingsley

Capital Markets

Represented Cannatrek Limited in conducting a $13m capital raising led by River Capital, and a sell down of CannTrust's Canada's stake in Cannatrek.
Advised Cricket Australia, the Australian men’s national cricket team, in an equity investment with the Australian Cricketers’ Association (ACA) into Rario, an India-based global cricket NFT platform with partners across Australia, Asia, the Caribbean, and the Americas.
Acted for ThinkMarkets, a premium multi-asset online brokerage headquartered in Melbourne, Australia, on raising US$10 million from institutional investors in the form of convertible notes.
Represented Titomic Limited (ASX: TTT), a Melbourne, Australia-headquartered company specialising in industrial-scale metal additive manufacturing, in a private placement and a share purchase plan to raise AU$9.5 million.
Acted for BirdDog Technology Limited (ASX: BDT), a world leader in network device interface and Internet protocol video technology, in its $133m initial public offering and associated capital raising.
Represented Australian antiviral drug development company Island Pharmaceuticals Limited (ASX: ILA) in its initial public offering and associated capital raising totaling AU$20.2 million.
Represented Rocketboots Limited (ASX: ROC), a Sydney, Australia-based developer of artificial intelligence software, in its initial public offering.
Represented Energy Technologies Ltd. (ASX: EGY) in connection with an underwritten entitlement offer raising AU$11 million in a placement of ordinary shares and attaching options.
Represented Yumbah Acquaculture Ltd in connection with its Underwritten Entitlement Offer of AU$9 million to shareholders of Yumbah Acquaculture Limited to fund the cash component of the acquisition of oyster farming concern Cameron of Tasmania Pty Ltd.
Representing Butn Limited, an Australian Fintech business, on its AU$12.5 million pre-IPO fund raising and oversubscribed initial public offering raising AU$20 million. Butn engages in B2B invoice factoring and has developed a number of key platform partnerships for its offering including KKR owned MYOB Limited.
Represented BirdDog Australia Pty Ltd in its AU$13.75m pre-IPO convertible note funding
Acting for Israeli company, N.G. Solutions Limited, on its successful and oversubscribed IPO on the ASX (ASX:NGS).
Advising Titomic Limited on its institutional placement of AU$19 million to new and existing institutional funds and international long term investors led by E&P Corporate Advisory and PAC Partners Securities.
Advising Evolution Capital Pty Ltd on an institutional placement of ordinary shares for Harris Technology Limited (ASX:HT8).
Advising Evolution Capital Pty Ltd on a AU$5 million institutional capital raising for MyFiziq Limited (ASX:MYQ).
Advising Evolution Capital Pty Ltd on the capital raising to fund Westgold into a controlling position in the Murchison Region and to retire pre-paid gold debt.
Advised on its convertible note pre-IPO funding round
Advising Imagion Biosystems Limited on its AU$2.5m placement and Non Renounceable Entitlement Offer.

Corporate/Mergers & Acquisitions

Represented Australia-based Countrywide Renewable Hydrogen Limited in its acquisition by ReNu Energy Limited (ASX: RNE), a renewables company. Countrywide Renewable Hydrogen focuses on originating renewable hydrogen production opportunities in Australia and abroad.
Represented Titomic Limited (ASX: TTT), a Melbourne, Australia-headquartered company specialising in industrial-scale metal additive manufacturing, in its acquisition of Dycomet Europe B.V., a Netherlands-based company offering low and medium pressure cold spray technology solutions to various industries.
Represented Yumbah Acquaculture Ltd in connection with its acquisition of all the shares in Cameron of Tasmania Pty Ltd, an oyster farming concern, for AU$20 million in cash and shares.
Represented Titomic Limited’s (ASX: TTT) subsidiary, Titomic USA, Inc., in its acquisition of the business, Tri-D Dynamics Inc., a specialised engineering firm based in San Francisco.
Advised Balance Internet Pty Ltd on all legal aspects of its sale to Publicis Group S.A.


Advising Cannatrek Ltd on bringing to market new cannabidiol (CBD) products on an exclusive basis to be sold under one of the Chemist Warehouse brands, adding to the other Cannatrek tetrahydrocannabinol (THC) cannabis products it sells.
Advising Cannatrek Ltd on its pre-IPO private placement of AU$10 million.
Advising NextLeaf Solutions Ltd on its Australian pre-IPO raising listing ahead of its listing on the Canadian Securities Exchange (CSE).
Advising PAC Partners as underwriter of the Althea Limited IPO.
Advising Cannatrek Limited on its joint ventures with Cannahub, IHL and Valens.

Work undertaken prior to joining K&L Gates

Equity capital markets including IPOs, right issues, private placements, SPPs, hybrids and convertibles in both underwritten and non-underwritten environments acting for issuers, lead managers and underwriters
Complex domestic and cross border M&A, strategic sales processes, takeovers and takeover defence in the energy and resources, transport and logistics, food and fibre, infrastructure and the general and technology services sector
General commercial work including negotiating complex take or pay and variable transport agreements with and for freight forwarders, minerals and mining companies, suppliers of construction products, grain producers and other agribusiness, access providers and steel producers
Major projects involving multiple work streams including infrastructure projects, complex tenders and joint ventures
Corporate governance matters including corporate structuring and restructuring, board policies, company secretarial advice, ASX listing rule advice, advice on ASIC policies and employee share plans
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel